Sentences with phrase «for pharmaceutical medicines»

Is there any alternative or substitute for pharmaceutical medicines to treat the patient during ill health?

Not exact matches

A new study published in the New England Journal of Medicine finds that Valeant Pharmaceuticals» infamous price hikes for a pair of heart drugs called nitroprusside and isoproterenol — whose prices were increased by 310 % and 720 %, respectively — had significant downstream effects on patient care.

Aurora Cannabis was up 2.5 % in early Wednesday trading; the U.K.'s GW Pharmaceuticals, which is vying for the first Food and Drug Administration (FDA) approved cannabis - based medicine in the U.S., rose more than 2 %; Canada's MedReleaf spiked 4 % while Aprhia had a more modest 1 % rise.

Adding Actelion's portfolio to our already strong Janssen Pharmaceuticals business is a unique opportunity for us to expand our portfolio with leading, differentiated in - market medicines and promising late - stage products.

The takeover interest in Tesaro underscores the pharmaceutical industry's strong appetite for the acquisition of biotechnology companies with promising medicines under development in lucrative sectors such as cancer treatment.

(Reuters)- Alnylam Pharmaceuticals Inc's RNAi - based drug that targets a rare genetic disease met the main goal of a key study, in a breakthrough for the new class of medicines that works by blocking disease - causing proteins.

And if your blog knew anything about the reality of the revolving door that exists between the FDA and pharmaceutical industry then you would understand why most medicines that have been used for thousands of years are demonized in favor of A) a chemical solution like Reglan, or B) soy - based baby formula, also created by the pharmaceutical industry.

In an open letter to Theresa May, leading British scientists urged the home secretary to add an exemption for «research pharmaceuticals being used to develop new medicines or progress neuroscience research», so that new treatments and experiments were not brought to a halt by the bill.

An intricate tale of «medicine, monopoly and malice», Fire in the Blood tells the story of how Western pharmaceutical companies and governments aggressively blocked access to low - cost Aids drugs for the countries of Africa and the global south in the years after 1996 — causing ten million or more unnecessary deaths — and the improbable group of people who decided to fight back.

«It is as bad as a very silent Ebola or a very silent Lassa fever,» suggested the medical doctor who formerly worked with global pharmaceutical giant, Pfizer with responsibility for Neurosciences and Sexual Medicine.

«A civil war has broken out among the most powerful players in the pharmaceutical industry — including brand - name and generic drug makers, and even your local pharmacists — with each blaming others for the rising price of medicine.»

Five years later, Gilead became the first pharmaceutical company to sign an agreement with the newly formed Medicines Patent Pool — an organisation formed to coordinate the licensing of patent - protected medicines so that they can be produced in generic form for low income countries.

In medicine today, physician - scientists and basic scientists supplement support for their research by applying their expertise part time to develop and test commercial products.1 In my own field, vision science, university - based researchers obtain additional funding through clinical and electrophysiologic studies, pathology, imaging, biochemistry, and animal model development performed for pharmaceutical and instrument companies.

The technology has been licensed to Cambridge spin - out company TeraView, who are developing it for use in the pharmaceutical industry in order to make medicines that are more easily released in the body.

He pointed to the sudden rise in share prices for pharmaceutical firms working on Ebola vaccines as one type of economic spur to ensure that medicines are there in an emergency, along with WHO's capacity to «prequalify» drugs as safe and effective so that they can be sold more cheaply and widely.

Arthritis is made to order for integrative medicine because there are many approaches that should be emphasized first — an anti-inflammatory diet and herbs like ginger and turmeric, water exercise, hypnosis or guided imagery, possibly Chinese medicine — before the selective use of pharmaceuticals.

In Chinese Medicine, Western Style, Jim Kling describes how Western pharmaceutical companies are building R&D facilities in China and thus expanding employment opportunities for researchers — but mostly for Chinese nationals trained in the West rather than Western scientists.

«What we are likely seeing is that the model of a vertically integrated pharmaceutical company capable of taking a molecule from discovery to market is in the process of disintegrating,» says Garret FitzGerald, chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania.

The university and industry must work together to overcome the fundamental challenges inherent in developing pharmaceuticals for the future,» says Lassina Badolo, Principal Scientist with H. Lundbeck A / S and an expert on the absorption of medicines in the body.

Triheptanoin is an investigational medicine being developed by Ultragenyx Pharmaceuticals for patients with fatty - acid metabolism disorders and Glucose Transporter Type 1 Deficiency Syndrome, which leads to epileptic seizures in young children.

One of the core beliefs at ISB is that medicine will become more and more personalized, with people sequencing their own genes and pharmaceutical companies developing drugs for groups with certain genetic characteristics.

For example, the best national pharmaceutical companies are starting to invest in the validation of plant - derived medicines in an attempt to lay claim to new medicines and compete with the conventional imported compounds, which make up over 70 % of the Brazilian market.

A team of researchers from the Massachusetts General Hospital (MGH) Center for Engineering in Medicine (MGH - CEM) have created a «liver on a chip,» a model of liver tissue that replicates the metabolic variations found throughout the organ and more accurately reflects the distinctive patterns of liver damage caused by exposure to environmental toxins, including pharmaceutical overdose.

«This is the first instance I am aware of where an academic drug discovery group moved a molecule designed to hopefully treat a chronic brain disorder all the way from early discovery to human trials without there being, at some point along the way, a pharmaceutical partner,» said P. Jeffrey Conn, Ph.D., Lee E. Limbird Professor of Pharmacology in the Vanderbilt University School of Medicine and director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD).

In 2010 two US pharmaceutical companies created a variant of an R - ATA allowing industrial - scale synthesis of sitagliptin, a medicine for type - 2 diabetes.

PHILADELPHIA --(April 19, 2018)-- The Wistar Institute and partners at the Perelman School of Medicine at the University of Pennsylvania, Inovio Pharmaceuticals, and GeneOne Life Science were recognized among the Top 10 Clinical Research Achievement Awards by the Clinical Research Forum for their ground - breaking phase 1 DNA - based Zika vaccine research — the first trial of a Zika vaccine in humans, which proved safe and effective.

Astellas Pharma is a global pharmaceutical company with a simple vision — to produce exceptional medicines that change tomorrow for patients in need.

iBET's infrastructure comprises 16 laboratories fully equipped with state - of - the - art technology (70 m2 each), including a BSL2 laboratory for working with viruses; a GMP Analytical Services Unit certified by the INFARMED (the Portuguese medicines authority, EMA Portuguese branch) and by DGAV (the Portuguese veterinary authority) for quality control and batch release of human and veterinary pharmaceuticals, biopharmaceuticals as well as experimental new drugs; a GMP Mass - Spectroscopy Unit that provides state - of - the - art MS services to the scientific community and Industry; a 2600 m2 bio-pilot plant supporting production and purification of proteins ATMPs and vaccines from bench top to 300 L scale and privileged access to GeniBET Biopharmaceuticals, an iBET spin - off producing ATMPs under cGMP certification for phase I / II / III clinical trials.

The SSPC leads the way for next generation drug manufacture and spans the entire pharmaceutical production chain from synthesis of the molecule, to the isolation of the material, and formulation of the medicine.

She is CEO of PsychoGenics Inc., a profitable preclinical CNS service company, CEO of PGI Drug Discovery LLC, a company engaged in psychiatric drug discovery with three partnered Phase II clinical programs and Adjunct Associate Professor of Neuroscience at Mount Sinai School of Medicine, Dr. Leahy has more than 25 years of experience in drug discovery, clinical develop and business development for pharmaceutical and biotechnology companies, including extensive knowledge of technology assessment, licensing, mergers and acquisitions, and strategic planning.

The symposium we've convened addresses the ways Organs - on - Chips technology is being used for drug development by pharmaceutical companies and for precision medicine by clinicians.

Finally, Sanford Consortium for Regenerative Medicine improves the state and local economy as more grant and philanthropic dollars flow into the region, and businesses expand as discoveries are translated into marketable pharmaceuticals, therapies, and cures.

Cells have become essential in modern medicine as therapies, vehicles for producing high ‑ value therapeutics, and tools for high ‑ throughput screening of pharmaceutical compounds.

The difference in a molecule's handedness is particularly important for pharmaceuticals, as it can mean the difference between a medicine and a poison.

Previous honorees include David Botstein of Princeton University and Ronald W. Davis and David S. Hogness of Stanford University School of Medicine for their seminal contributions to the concepts and methods of creating a human genetic map, leading to the identification of thousands of disease genes; Julian Adams of Infinity Pharmaceuticals, Alfred Goldberg of Harvard Medical School and Kenneth Anderson and Paul Richardson, both of Dana - Farber Cancer Institute, for the development of bortezomib, a drug that has altered the lives of hundreds of thousands of people with multiple myeloma; Alain Carpentier of Hôpital Européen Georges Pompidou in Paris and Robert S. Langer of MIT for innovations in bioengineering.

However, with few exceptions, the stem cell and regenerative medicine industry has remained inadequately capitalized to carry out large - scale clinical trials independently, and major pharmaceutical firms have tended to show more interest in the use of hiPSCs as a source of large, pure populations of specific somatic cells for use in drug compound screening and toxicology tests, than they have in therapeutic uses of stem cells and their derivatives.

For those with very marketable degrees in clinical medicine, the lure of private practice and industry can be strong; three of Voglmaier's colleagues opted for research careers in the pharmaceutical industry, whereas the other two chose private practiFor those with very marketable degrees in clinical medicine, the lure of private practice and industry can be strong; three of Voglmaier's colleagues opted for research careers in the pharmaceutical industry, whereas the other two chose private practifor research careers in the pharmaceutical industry, whereas the other two chose private practice.

GMP Analytical Services Unit certified by the INFARMED (the Portuguese medicines authority, EMA Portuguese branch) and by DGAV (the Portuguese veterinary authority) for quality control and batch release of human and veterinary pharmaceuticals, biopharmaceuticals as well as experimental new drugs.

SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, personalized molecular diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid tumors.

Having been a pharmaceutical marketer for the better part of 20 years, I spent most of my energy highlighting the value of traditional Western medicine to cure all that ails us.

One was a CEO of a major pharmaceutical company and the other was an activist for worker's rights in a union in Philadelphia, who started using food as medicine to heal his brother's colitis in the 1940s.

I'm all the more grateful that I've chosen food as my medicine and if need be turn to herbal medicine or the like and that I have done my best to avoid the pharmaceutical products for over the past two and a half decades!

Before I went to med school I worked at the NYU School of Medicine's Mental Health and Addictive Disorders Research program as a research coordinator for pharmaceutical trials for adult ADHD medications.

In conventional medicine, the treatments that are recommended for this diagnosis consist of cognitive behavioral therapy, anti-depressant pharmaceutical medications, graded exercise therapy, sleep hygiene, discouraging over-sleeping, and referrals to support groups.

Before the advent of modern pharmaceuticals, women frequently used herbs as medicine for themselves and their families.

However, since a diet can not be patented, mainstream medicine has instead focused on pharmaceutical drugs and vaccines to combat diseases like Alzheimer's, as such drugs are seen as a financial windfall for pharmaceutical companies, with so many Americans in the «Baby Boomer» age group entering into their senior years.

Finally, the supplements partisans accuse the pharmaceutical industry and mainstream medicine of being greedy, out for the big bucks, and eager to cover up miracle drugs that would end disease and, in consequence, eliminate the need for their own less effective drugs.

It's become normal to die of cancer, to get chemotherapy, to accept pharmaceutical drugs as «medicine» when really it's nothing but a temporary fix that doesn't do a single thing for the cause (s) of the problem to create a sustainable fix.

Once I immersed myself in research, became my own health advocate, self - experimented, and adopted healing strategies in the realms of integrative medicine and nutritional therapy, I began to experience tangible improvements and eventually tapered from my pharmaceutical drugs, replacing the deleterious pill - for - every - ill, symptom suppressive approach that predominates in biomedicine with the bio-individualized, therapeutic partnership and root - cause resolution paradigm embraced by functional medicine.

It is assumed that conventional medicine and the pharmaceutical industry are diligently looking for the cures for cancer.